Firms explore digital mammography
Although mammography's resolution requirements have kept thatmodality bound to film, efforts are under way to bridge the digitalgap. Both Bennett X-ray and Lorad displayed works-in-progressdigital mammography technology at the 1991 RSNA exhibition.
Although mammography's resolution requirements have kept thatmodality bound to film, efforts are under way to bridge the digitalgap. Both Bennett X-ray and Lorad displayed works-in-progressdigital mammography technology at the 1991 RSNA exhibition.
Initial applications will be in guiding stereotactic fine-needlebiopsies, although the companies also see a future for digitalbreast exams.
Both companies use charge-coupled device (CCD) technology toacquire the digital images. Once acquired, contrast and brightnessin the image can be manipulated to better detect tumors. Digitalmammography should also help reduce radiation exposure.
"It enables you to get a real-time image, the major benefitof which is to reduce procedure time without taking additionalshots and exposing people to additional radiation," saidLorad president Hal Kirshner.
Bennett uses a 1024 x 1280-pixel screen for its digital mammographysystem, but has developed a 2000 x 2000-pixel monitor for thesystem that may give it the resolution needed for soft-copy diagnosis.Bennett can also combine standard digital radiography with itslower resolution requirements and digital mammography on the samesystem, said president Calvin Kleinman.
"Until we feel that the resolution of image is equal toor greater than film-screen mammography, we will not bring iton as a product," Kleinman said.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
